메뉴 건너뛰기




Volumn 27, Issue 7, 2007, Pages 505-508

Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CYTOCHROME P450; DIGOXIN; PROPAFENONE; RIFAMPICIN; VITAMIN K GROUP; WARFARIN;

EID: 34250351489     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727070-00008     Document Type: Article
Times cited : (20)

References (20)
  • 1
    • 0038350660 scopus 로고    scopus 로고
    • Therapeutic apheresis: A summary of current indication categories endorsed by the AABB and the American Society for Apheresis
    • Smith JW, Weinstein R. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003; 43: 820-2
    • (2003) Transfusion , vol.43 , pp. 820-822
    • Smith, J.W.1    Weinstein, R.2
  • 2
    • 0344395547 scopus 로고    scopus 로고
    • Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis
    • Klemmel PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003; 42: 1149-53
    • (2003) Am J Kidney Dis , vol.42 , pp. 1149-1153
    • Klemmel, P.J.1    Chalermskulrat, W.2    Reif, M.S.3
  • 3
    • 0032783540 scopus 로고    scopus 로고
    • Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis
    • Lennertz A, Parhofer KG, Samtleben W, et al. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999; 3: 227-33
    • (1999) Ther Apher , vol.3 , pp. 227-233
    • Lennertz, A.1    Parhofer, K.G.2    Samtleben, W.3
  • 4
    • 0032792850 scopus 로고    scopus 로고
    • Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation
    • Bosch T, Buhmann R, Lennertz A, et al. Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation. Ther Apher 1999; 3: 252-6
    • (1999) Ther Apher , vol.3 , pp. 252-256
    • Bosch, T.1    Buhmann, R.2    Lennertz, A.3
  • 5
    • 0343932759 scopus 로고    scopus 로고
    • Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: New insights into underlying biochemical mechanisms
    • Furlan M, Lammle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112-4
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 1112-1114
    • Furlan, M.1    Lammle, B.2
  • 6
    • 0017606132 scopus 로고
    • Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis
    • Dau PC, Lindstrom JM, Cassel CK, et al. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977; 297: 1134-40
    • (1977) N Engl J Med , vol.297 , pp. 1134-1140
    • Dau, P.C.1    Lindstrom, J.M.2    Cassel, C.K.3
  • 7
    • 0035675528 scopus 로고    scopus 로고
    • Therapeutic plasma exchange in the intensive care setting
    • Samtleben W, Mistry-Burchardi N, Hartmann B, et al. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001; 5: 351-7
    • (2001) Ther Apher , vol.5 , pp. 351-357
    • Samtleben, W.1    Mistry-Burchardi, N.2    Hartmann, B.3
  • 8
    • 34250312389 scopus 로고    scopus 로고
    • Official propafenone FDA information [online]. Available from: http: //www.drugs.com/pro/PROPAFENONE.html [Accessed 2007 Mar 30]
    • Official propafenone FDA information [online]. Available from: http: //www.drugs.com/pro/PROPAFENONE.html [Accessed 2007 Mar 30]
  • 10
    • 0035064433 scopus 로고    scopus 로고
    • Warfarin toxicity in the emergency department: Recommendations for management
    • Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001; 13: 91-7
    • (2001) Emerg Med (Fremantle) , vol.13 , pp. 91-97
    • Cruickshank, J.1    Ragg, M.2    Eddey, D.3
  • 11
    • 2942516058 scopus 로고    scopus 로고
    • Pattern of acute poisonings in childhood in Ankara: What has changed in twenty years?
    • Andiran N, Sarikayalar F. Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years? Turk J Pediatr 2004; 46: 147-2
    • (2004) Turk J Pediatr , vol.46 , pp. 147-142
    • Andiran, N.1    Sarikayalar, F.2
  • 13
    • 0025737392 scopus 로고
    • Serum digoxin levels related to plasma propafenone levels during concomitant treatment
    • Bigot MC, Debruyne D, Bonnefoy L, et al. Serum digoxin levels related to plasma propafenone levels during concomitant treatment. J Clin Pharmacol 1991; 31: 521-6
    • (1991) J Clin Pharmacol , vol.31 , pp. 521-526
    • Bigot, M.C.1    Debruyne, D.2    Bonnefoy, L.3
  • 14
    • 0023276452 scopus 로고
    • Interaction between warfarin and propafenone in healthy volunteer subjects
    • Kates RE, Yee YG, Kirsten EB. Interaction between warfarin and propafenone in healthy volunteer subjects. Clin Pharmacol Ther 1987; 42: 305-11
    • (1987) Clin Pharmacol Ther , vol.42 , pp. 305-311
    • Kates, R.E.1    Yee, Y.G.2    Kirsten, E.B.3
  • 15
    • 0007677180 scopus 로고
    • Effect of plasma exchange on drug removal
    • Valbonesi M, Pineda AA, Biggs JC, editors, Milan, Italy: Wichtig Editore
    • Sketris IS, Parker WA, Jones JV. Effect of plasma exchange on drug removal. In: Valbonesi M, Pineda AA, Biggs JC, editors. Therapeutic hemapheresis. Milan, Italy: Wichtig Editore, 1986: 15-20
    • (1986) Therapeutic hemapheresis , pp. 15-20
    • Sketris, I.S.1    Parker, W.A.2    Jones, J.V.3
  • 16
    • 0033932352 scopus 로고    scopus 로고
    • Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: Timing is important for maximizing clearance
    • Zdunek M, Mitra A, Mokrzycki MH. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis 2000; 36: 177-83
    • (2000) Am J Kidney Dis , vol.36 , pp. 177-183
    • Zdunek, M.1    Mitra, A.2    Mokrzycki, M.H.3
  • 17
    • 0025200720 scopus 로고
    • Complications of plasma exchange in patients with neurological diseases
    • Henze T, Prange HW, Talartschik J, et al. Complications of plasma exchange in patients with neurological diseases. Klin Wochenschr 1990; 68: 1183-8
    • (1990) Klin Wochenschr , vol.68 , pp. 1183-1188
    • Henze, T.1    Prange, H.W.2    Talartschik, J.3
  • 18
    • 0029886356 scopus 로고    scopus 로고
    • Clinically important drug interactions with anticoagulants: An update
    • Harder S, Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet 1996; 30: 416-44
    • (1996) Clin Pharmacokinet , vol.30 , pp. 416-444
    • Harder, S.1    Thurmann, P.2
  • 19
    • 0042163137 scopus 로고    scopus 로고
    • Pharmacokinetic interactions with rifampicin: Clinical relevance
    • Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819-50
    • (2003) Clin Pharmacokinet , vol.42 , pp. 819-850
    • Niemi, M.1    Backman, J.T.2    Fromm, M.F.3
  • 20
    • 0141520307 scopus 로고    scopus 로고
    • High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: Microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes
    • Yamamoto T, Suzuki A, Kohno Y. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes. Xenobiotica 2003; 33: 823-39
    • (2003) Xenobiotica , vol.33 , pp. 823-839
    • Yamamoto, T.1    Suzuki, A.2    Kohno, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.